Literature DB >> 9121438

The casein kinase II beta subunit binds to Mos and inhibits Mos activity.

M Chen1, D Li, E G Krebs, J A Cooper.   

Abstract

Mos is a germ cell-specific serine/threonine kinase and is required for Xenopus oocyte maturation. Active Mos stimulates a mitogen-activated protein kinase (MAPK) by directly phosphorylating and activating MAPK kinase (MKK). We report here that the Xenopus homolog of the beta subunit of casein kinase II (CKII beta) binds to and regulates Mos. The Mos-interacting region of CKII beta was mapped to the C terminus. Mos bound to CKII beta in somatic cells ectopically expressing Mos and CKII beta as well as in unfertilized Xenopus eggs. CKII beta inhibited Mos-mediated MAPK activation in rabbit reticulocyte lysates and repressed MKK activation by v-Mos in a coupled kinase assay. In addition, microinjection of CKII beta mRNA into Xenopus oocytes inhibited progesterone-induced meiotic maturation and MAPK activation, presumably by binding of CKII beta to Mos and thereby inhibiting MAPK activation. Moreover, this inhibitory phenotype could be rescued by another protein that binds to CKII beta, CKII alpha. The ability of ectopic CKII beta to inhibit meiotic maturation and the detection of a complex between endogenous Mos and CKII beta suggest that CKII beta may act as an inhibitor of Mos during oocyte maturation, perhaps setting a threshold beyond which Mos protein must accumulate before it can activate the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121438      PMCID: PMC232037          DOI: 10.1128/MCB.17.4.1904

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

1.  Construction of an improved host strain for two hybrid screening.

Authors:  H E Feilotter; G J Hannon; C J Ruddell; D Beach
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

2.  Biosynthesis of casein kinase II in lymphoid cell lines.

Authors:  B Lüscher; D W Litchfield
Journal:  Eur J Biochem       Date:  1994-03-01

Review 3.  MAP kinase kinase kinase, MAP kinase kinase and MAP kinase.

Authors:  C J Marshall
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

4.  Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites.

Authors:  Y Gotoh; S Matsuda; K Takenaka; S Hattori; A Iwamatsu; M Ishikawa; H Kosako; E Nishida
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

5.  A majority of casein kinase II alpha subunit is tightly bound to intranuclear components but not to the beta subunit.

Authors:  J Stigare; N Buddelmeijer; A Pigon; E Egyhazi
Journal:  Mol Cell Biochem       Date:  1993-12-08       Impact factor: 3.396

6.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.

Authors:  B J Mayer; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs.

Authors:  W H Colledge; M B Carlton; G B Udy; M J Evans
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

8.  Requirement for the MAP kinase kinase/MAP kinase cascade in Xenopus oocyte maturation.

Authors:  H Kosako; Y Gotoh; E Nishida
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

9.  Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues.

Authors:  C F Zheng; K L Guan
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

10.  Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1.

Authors:  D R Alessi; Y Saito; D G Campbell; P Cohen; G Sithanandam; U Rapp; A Ashworth; C J Marshall; S Cowley
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  34 in total

1.  Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins.

Authors:  M Kusk; R Ahmed; B Thomsen; C Bendixen; O G Issinger; B Boldyreff
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis.

Authors:  J Roig; A Krehan; D Colomer; W Pyerin; E Itarte; M Plana
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Functional analysis of CK2beta-derived synthetic fragments.

Authors:  F Meggio; O Marin; S Sarno; L A Pinna
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Interactions of protein kinase CK2 subunits.

Authors:  I Korn; S Gutkind; N Srinivasan; T L Blundell; C C Allende; J E Allende
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme.

Authors:  K Niefind; B Guerra; I Ermakowa; O G Issinger
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

7.  A novel regulatory element determines the timing of Mos mRNA translation during Xenopus oocyte maturation.

Authors:  Amanda Charlesworth; John A Ridge; Leslie A King; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

Review 8.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

9.  Restricted specificity of Xenopus TFIIIA for transcription of somatic 5S rRNA genes.

Authors:  Romi Ghose; Mariam Malik; Paul W Huber
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Authors:  Jennifer Yinuo Cao; Kathy Shire; Cameron Landry; Gerald D Gish; Tony Pawson; Lori Frappier
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.